
|Videos|June 26, 2020
Clinical Ramifications of Pneumococcal Vaccine Development
Author(s)Contagion® Editorial Staff
Dr. Luwy Musey, executive director in biologics, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Advertisement
Segment Description: Dr. Luwy Musey, executive director in biologics, vaccine clinical research, Merck Research Laboratories, discusses what clinicians need to know about the latest PCVs.
Part 1: Developments in Pneumococcal Conjugate Vaccines
Newsletter
Stay ahead of emerging infectious disease threats with expert insights and breaking research. Subscribe now to get updates delivered straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Contagion Live
1
US Measles Cases Near 2,000 in 2025 as Multi-State Outbreaks Expand
2
Public Health Wake-Up Call: Will the US Lose Measles Elimination Status?
3
Recent Florida Cases of Chikungunya Linked to Cuba Travelers, Reminder Vector-Borne Illness is Still Circulating
4
CDC Adopts Individual-Based Decision-Making for Hepatitis B Vaccine for Infants
5





















































































































































































































































































